1. Home
  2. FINV vs COLL Comparison

FINV vs COLL Comparison

Compare FINV & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FINV

FinVolution Group

HOLD

Current Price

$4.96

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$46.17

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
COLL
Founded
2007
2002
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FINV
COLL
Price
$4.96
$46.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$11.55
$51.50
AVG Volume (30 Days)
1.0M
481.4K
Earning Date
11-19-2025
02-26-2026
Dividend Yield
5.59%
N/A
EPS Growth
27.76
N/A
EPS
1.50
1.63
Revenue
$1,969,555,571.00
$757,067,000.00
Revenue This Year
$6.02
$26.35
Revenue Next Year
N/A
$3.67
P/E Ratio
$3.45
$30.01
Revenue Growth
8.81
26.34
52 Week Low
$4.70
$23.23
52 Week High
$11.08
$50.79

Technical Indicators

Market Signals
Indicator
FINV
COLL
Relative Strength Index (RSI) 38.33 46.23
Support Level $5.17 $44.51
Resistance Level $5.49 $49.17
Average True Range (ATR) 0.21 1.65
MACD 0.00 -0.41
Stochastic Oscillator 3.03 26.77

Price Performance

Historical Comparison
FINV
COLL

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: